1. Home
  2. NIM vs XGN Comparison

NIM vs XGN Comparison

Compare NIM & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Select Maturities Municipal Fund

NIM

Nuveen Select Maturities Municipal Fund

N/A

Current Price

$8.67

Market Cap

116.6M

Sector

Finance

ML Signal

N/A

Logo Exagen Inc.

XGN

Exagen Inc.

SELL

Current Price

$8.30

Market Cap

110.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NIM
XGN
Founded
1992
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.6M
110.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NIM
XGN
Price
$8.67
$8.30
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $10.14
AVG Volume (30 Days)
44.9K
★ 260.2K
Earning Date
01-01-0001
11-03-2026
Dividend Yield
★ 3.46%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.02
Revenue Next Year
N/A
$10.28
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.46
$2.59
52 Week High
$9.94
$12.23

Technical Indicators

Market Signals
Indicator
NIM
XGN
Relative Strength Index (RSI) 39.64 54.19
Support Level $8.46 $6.83
Resistance Level $9.47 $8.89
Average True Range (ATR) 0.17 0.41
MACD -0.00 -0.08
Stochastic Oscillator 41.39 30.56

Price Performance

Historical Comparison
NIM
XGN

About NIM Nuveen Select Maturities Municipal Fund

Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued. The fund has single operating segment.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: